Galkanezumab Testmiljö
Galkanezumab
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD et al. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019;20(1):6.
EMA. Emgality. CHMP assessment report 2018-09-20.
Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21(24):3365-9.
Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM et al. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine. Regul Toxicol Pharmacol. 2019;106(0):224-238.
Noseda R, Bedussi F, Gobbi C, Zecca C, Ceschi A. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database. Cephalalgia. 2021;41(7):789-798.
- Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD et al. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019;20(1):6.
- EMA. Emgality. CHMP assessment report 2018-09-20.
- Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21(24):3365-9.
- Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM et al. Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine. Regul Toxicol Pharmacol. 2019;106(0):224-238.
- Noseda R, Bedussi F, Gobbi C, Zecca C, Ceschi A. Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database. Cephalalgia. 2021;41(7):789-798.